Deerfield Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Deerfield Management’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,449,103	Closed	-$446M	–	149
2015 Q1	$446M	Buy	4,449,103 +1,500,000	+51%	+$99.9M	14.45%	1
2014 Q4	$155M	Buy	2,949,103 +436,943	+17%	+$12.8M	5.56%	2
2014 Q3	$64.5M	Buy	2,512,160 +528,122	+27%	+$11.2M	2.35%	9
2014 Q2	$44.2M	Sell	1,984,038 -4,952	-0.2%	-$108K	1.78%	16
2014 Q1	$61.2M	Buy	+1,988,990	New	+$53.4M	2.5%	8

Deerfield Management's ASPX Position: Q2 2015 in Review

Deerfield Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 4,449,103 shares — an estimated $446M sold.

Deerfield Management first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $446M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Deerfield Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Deerfield Management sold 4,449,103 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $446M.
Deerfield Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
Deerfield Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $446M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Deerfield Management's 13F filing for Q2 2015, filed 14 Aug 2015.